Antioxidant Thymoquinone and Its Potential in the Treatment of Neurological Diseases

被引:28
作者
Isaev, Nickolay K. [1 ,2 ]
Genrikhs, Elizaveta E. [1 ]
Stelmashook, Elena V. [1 ]
机构
[1] Res Ctr Neurol, Moscow 125367, Russia
[2] Moscow MV Lomonosov State Univ, Biol Fac, Moscow 119991, Russia
关键词
thymoquinone; ischemia; Alzheimer's disease; Parkinson's disease; traumatic brain injury; oxidative stress; neuroprotection; LONG-TERM POTENTIATION; NIGELLA-SATIVA SEEDS; OXIDATIVE STRESS; BRAIN-INJURY; INDUCED NEUROTOXICITY; LIPID-PEROXIDATION; ALPHA-SYNUCLEIN; IN-VIVO; RAT; NEURODEGENERATION;
D O I
10.3390/antiox12020433
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oxidative stress is one of the main pathogenic factors of neuron damage in neurodegenerative processes; this makes it an important therapeutic target to which the action of neuroprotectors should be directed. One of these drugs is thymoquinone. According to modern data, this substance has a wide range of pharmacological activity, including neuroprotective, which was demonstrated in experimental modeling of various neurodegenerative diseases and pathological conditions of the brain. The neuroprotective effect of thymoquinone is largely due to its antioxidant ability. Currently available data show that thymoquinone is an effective means to reduce the negative consequences of acute and chronic forms of cerebral pathology, leading to the normalization of the content of antioxidant enzymes and preventing an increase in the level of lipid peroxidation products. Antioxidant properties make this substance a promising basis for the development of prototypes of therapeutic agents aimed at the treatment of a number of degenerative diseases of the central nervous system.
引用
收藏
页数:14
相关论文
共 91 条
[1]   Celastrol and thymoquinone alleviate aluminum chloride-induced neurotoxicity: Behavioral psychomotor performance, neurotransmitter level, oxidative-inflammatory markers, and BDNF expression in rat brain [J].
Abbas, Faten ;
Eladl, Mohamed Ahmed ;
El-Sherbiny, Mohamed ;
Abozied, Nadia ;
Nabil, Amaal ;
Mahmoud, Shereen M. ;
Mokhtar, Hatem I. ;
Zaitone, Sawsan A. ;
Ibrahim, Dalia .
BIOMEDICINE & PHARMACOTHERAPY, 2022, 151
[2]   A potential mechanism for the ameliorative effect of thymoquinone on pentylenetetrazole-induced kindling and cognitive impairments in mice [J].
Abdel-Zaher, Ahmed O. ;
Farghaly, Hanan S. M. ;
Farrag, Magda M. Y. ;
Abdel-Rahman, Mahran S. ;
Abdel-Wahab, Basel A. .
BIOMEDICINE & PHARMACOTHERAPY, 2017, 88 :553-561
[3]   Thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration [J].
Abdelwahab, Siddig Ibrahim ;
Sheikh, Bassem Yousef ;
Taha, Manal Mohamed Elhassan ;
How, Chee Wun ;
Abdullah, Rasedee ;
Yagoub, Umar ;
El-Sunousi, Rashad ;
Eid, Eltayeb E. M. .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2013, 8 :2163-2172
[4]   Quantification and evaluation of thymoquinone loaded mucoadhesive nanoemulsion for treatment of cerebral ischemia [J].
Ahmad, Niyaz ;
Ahmad, Rizwan ;
Alam, Md Aftab ;
Samim, Mohd ;
Iqbal, Zeenat ;
Ahmad, Farhan Jalees .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2016, 88 :320-332
[5]   Neuroprotective effects of thymoquinone against transient forebrain ischemia in the rat hippocampus [J].
Al-Majed, Abdulhakeem A. ;
Al-Omar, Fadhel A. ;
Nagi, Mahmoud N. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 543 (1-3) :40-47
[6]   Neuroprotective efficacy of thymoquinone against amyloid beta-induced neurotoxicity in human induced pluripotent stem cell-derived cholinergic neurons [J].
Alhibshi, A. H. ;
Odawara, A. ;
Suzuki, I .
BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2019, 17 :122-126
[7]   2018 Alzheimer's disease facts and figures [J].
不详 .
ALZHEIMERS & DEMENTIA, 2018, 14 (03) :367-425
[8]   Therapeutic impact of thymoquninone to alleviate ischemic brain injury via Nrf2/HO-1 pathway [J].
Amin, Nashwa ;
Du, Xiaoxue ;
Chen, Shijia ;
Ren, Qiannan ;
Hussien, Azhar B. ;
Botchway, Benson O. A. ;
Hu, Zhiying ;
Fang, Marong .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2021, 25 (07) :597-612
[9]  
[Anonymous], 2008, Guidelines for drinking water-quality. Third Edition incorporating the First and Second addenda Edition (Volume 1). Recommendations, V1
[10]   Thymoquinone prevents neurodegeneration against MPTP in vivo and modulates α-synuclein aggregation in vitro [J].
Ardah, Mustafa T. ;
Merghani, Madiha Mohieldin ;
Haque, M. Emdadul .
NEUROCHEMISTRY INTERNATIONAL, 2019, 128 :115-126